Therapeutic Asset Ratings
1,179 results matching 1 filter
91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Sti-6129
Refractory Precursor T-Lymphoblastic Lymphoma/Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Succimer
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P1
CC
(43)
Succimer
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
P1
CC
(43)
Succimer
Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Succimer
Myelodysplastic/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Female Reproductive Organ Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Cervical Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Endometrial Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Vaginal Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Cervical Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Talazoparib
Vaginal Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Tgfbr2 Ko Car27/Il-15 Nk Cells
Lymphoid System Disorder
M.D. Anderson Cancer Center
P1
CC
(43)
Tgfbr-2 Ko Cd70 Car Nk
Clear Cell Adenocarcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Trametinib
Amyotrophic Lateral Sclerosis Type 19
M.D. Anderson Cancer Center
P1
CC
(43)
Valemetostat
Prostate Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Valemetostat
Nonpapillary Renal Cell Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Valemetostat
Urothelial Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Valemetostat
Renal Cell Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Vedolizumab
Lung Carcinoma In Situ
M.D. Anderson Cancer Center
P1
CC
(43)
Vedolizumab
Lung Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Vedolizumab
Lung Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
vg2025
Peritoneal Carcinomatosis
M.D. Anderson Cancer Center
P1
CC
(43)
Vistusertib
Hereditary Breast Ovarian Cancer Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Vistusertib
BRCA2-Related Cancer Predisposition
M.D. Anderson Cancer Center
P1
CC
(43)
Showing 976 to 1000 of 1,179 assets
Previous
Page 40 of 48
Next
